Abstract
The American Cancer Society (ACS) and Coalition of Cancer Cooperative Groups (CCCG) provide a clinical trial (CT) information/matching/eligibility service (Clinical Trials Matching Service [CTMS]). Patients' demographic and clinical data, enrollment status, and self-reported barriers to CT participation were analyzed to assess enrollment rates and determinants of enrollment. During 3 years beginning October 1, 2007, the CTMS served 6,903 patients via the ACS call center. Among the 1,987 patients with follow-up information on enrollment, 219 (11.0%) enrolled in a CT; 48 of these 219 enrollees chose a CT they found via the CTMS. Patients were less likely to enroll if they had poor ECOG performance status (P = 0.032); were African American (P = 0.0003), were uninsured or had Medicaid coverage (P = 0.024), or had lower stage disease (P = 0.018). Enrollment varied by trial type/cancer site/system (P = .026). Several barriers significantly predicted nonenrollment. Broader availability of a CTMS might help improve patient participation in cancer clinical trials.
Similar content being viewed by others
References
Institute of Medicine (2010) A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program. National Academies Press, Washington, DC
Dugas M, Amler S, Lange M, Gerss J, Breil B, Kopcke W (2009) Estimation of patient accrual rates in clinical trials based on routine data from hospital information systems. Methods Inf Med 48:263–6
Scott R, Scoggins J (2008) Practicing on the tip of an information iceberg? Evidence of underpublication of registered clinical trials in oncology. Oncologist 13:925–9
Gregory CA, Chabner BA (2008) One in five cancer clinical trials is published: A terrible symptom—what's the diagnosis? Oncologist 13:923–4
Institute of Medicine (2008) Improving the quality of cancer clinical trials: Workshop summary. National Academies Press, Washington, DC
Ford JG, Howerton MW, Bolen S, Gary TL, Lai GY, Tilburt J, Gibbons MC, Baffi C, Wilson RF, Feuerstein CJ, Tanpitukpongse P, Powe NR, Bass EB (2005) Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials. Evidence Report/Technology Assessment No 05-E019-2. Prepared by the Johns Hopkins University Evidence-based Practice Center, Baltimore MD
Comis RL, Aldigé CR, Stovall EL, Krebs LU, Risher PJ, Taylor HJ (2000) A Quantitative Survey of Public Attitudes Towards Cancer Clinical Trials. http://www.cancertrialshelp.org/CTHpdf/308-9.pdf
Comis RL, Miller JD, Aldige CR, Krebs L, Stoval E (2003) Public attitudes toward participation in cancer clinical trials. J Clin Oncol 21:830–835
Coalition of Cancer Cooperative Groups (July 2006) The clinical trial awareness gap: Coalition study reveals high satisfaction, low participation. Clinical Trial Matters. http://www.cancertrialshelp.org/CTHpdf/newsletterjuly2006.pdf. Accessed May 28, 2010
Umutyan A, Chiechi C, Beckett LA, Paterniti DA, Turrell C, Gandara DR, Davis SW, Wun T, Chen MS Jr, Lara PN Jr (2008) Overcoming barriers to cancer clinical trial accrual: impact of a mass media campaign. Cancer 112(1):212–9
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–55
Commission on Cancer. Public Benchmark Reports, Cases Diagnosed 2000–2008. http://cromwell.facs.org/BMarks/BMPub/Ver10/bm_reports.cfm. Accessed December 1, 2010
Meropol NJ, Buzaglo JS, Millard J, Damjanov N, Miller SM, Ridgway C, Ross EA, Sprandio JD, Watts P (2007) Barriers to clinical trial participation as perceived by oncologists and patients. J Natl Compr Canc Netw 5:655–64
Siegel R, Ward E, Brawley O, Jemal A (2010) Cancer statistics, 2010. CA Cancer J Clin 61:212–36
Baquet CR, Commiskey P, Mullins CD, Mishra SI (2006) Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors. Cancer Detect Prev 30(1):24–33
Park ER, Weiss ES, Moy B (2007) Recruiting and enrolling minority patients to cancer clinical trials. J Community Oncol 4:254–7
Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA 291:2720–6
Lara PN Jr, Paterniti DA, Chiechi C, Turrell C, Morain C, Horan N, Montell L, Gonzalez J, Davis S, Umutyan A, Martel CL, Gandara DR, Wun T, Beckett LA, Chen MS Jr (2005) Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol 23(36):9282–9
Clegg LX, Potosky AL, Harlan LC, Hankey BF, Hoffman RM, Stanford JL, Hamilton AS (2001) Comparison of self-reported initial treatment with medical records: Results from the Prostate Cancer Outcomes Study. Am J Epidemiol 154:582–7
Phillips K-A, Milne RL, Buys S, Friedlander ML, Ward JH, McCredie MRE, Giles GG, Hopper JL (2005) Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry. J Clin Oncol 23(21):4679–86
Klabunde CN, Keating NL, Potosky AL, Ambs A, Hei Y, Hornbrook MC, Ganz PA (2011) A population-based assessment of specialty physician involvement in cancer clinical trials. J Natl Cancer Inst 103(5):384–97
Metz JM, Coyle C, Hudson C, Hampshire M (2005) An Internet-based cancer clinical trials matching resource. J Med Internet Res 7(3):e24
Atkinson NL, Saperstein SL, Massett HA, Leonard CR, Grama L, Manrow RR (2008) Using the Internet to search for cancer clinical trials: a comparative audit of clinical trial search tools. Cont Clin Trials 29(4):555–64
Simon C, Hegedus S (2005) Exploring websites on cancer clinical trials: an empirical review. Cont Clin Trials 26:530–3
Moffitt K, Brogan F, Brown C, Kasper M, Rosenblatt J, Smallridge R, Sullivan D, Kromrey J (2010) Statewide cancer clinical trial navigation service. J Oncol Pract 6:127–32
Funding and Financial Disclosures
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gansler, T., Jin, M., Bauer, J. et al. Outcomes of a Cancer Clinical Trial Matching Service. J Canc Educ 27, 11–20 (2012). https://doi.org/10.1007/s13187-011-0296-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13187-011-0296-x